Posts

Showing posts from September, 2017

Scientists find key cues to regulate bone-building cells

Image
Micrographs present the distinction between handled and untreated bone cells in a mouse mannequin of extreme bone loss. Wisconsin researchers have recognized two native protein components that assist maintain mesenchymal stem cells -- the grasp cells that make bone and cartilage -- comfortable within the laboratory dish. The work may in the future assist make regenerating misplaced bone in sufferers a actuality. Credit score: Wan-Ju Li The prospect of regenerating bone misplaced to most cancers or trauma is a step nearer to the clinic as College of Wisconsin-Madison scientists have recognized two proteins present in bone marrow as key regulators of the grasp cells answerable for making new bone. In a examine printed on-line within the journal  Stem Cell Studies , a workforce of UW-Madison scientists stories that the proteins govern the exercise of mesenchymal stem cells -- precursor cells present in marrow that make bone and ca...

Researchers engineer new thyroid cells

Image
Researchers have found a brand new environment friendly strategy to generate thyroid cells, often known as thyrocytes, utilizing genetically modified embryonic stem cells. Credit score: © kentoh / Fotolia Researchers have found a brand new environment friendly strategy to generate thyroid cells, often known as thyrocytes, utilizing genetically modified embryonic stem cells. The findings, which seem within the journal  Stem Cell Experiences , are step one to growing an identical protocol utilizing human stem cells that may permit the modeling of thyroid illness to higher perceive its causes and the event of therapies. Thyroid problems have an effect on roughly 10 p.c of the U.S. inhabitants and embrace Grave's illness or Hashimoto's illness, which may end up in hyper or hypothyroidism, thyroid nodules, goiter or most cancers. Researchers from Boston College Faculty of Medication (BUSM), engineered mouse embryonic stem cells c...

Human brain 'organoids' offer new insight into rare developmental disease

MDS is caused by a deletion of a section of human chromosome 17 containing genes important for neural development. The result is a brain whose outer layer, the neocortex, which is normally folded and furrowed to fit more brain into a limited skull, instead has a smooth appearance (lissencephaly) and is often smaller than normal (microcephaly). The disease is accompanied by severe seizures and intellectual disabilities, and few infants born with MDS survive beyond childhood. In the new study -- published online January 19, 2017 in  Cell Stem Cell  -- the research team transformed skin cells from MDS patients and normal adults into neural stem cells, which they placed in a 3 dimensional culture system to grow organoid models of the human neocortex with and without the genetic defect that causes MDS. Closely observing the development of these MDS organoids over time revealed that many neural stem cells die off at early stages of development, and others exhibit defects in c...

Induced pluripotent stem cells don't increase genetic mutations

Despite its immense promise, adoption of iPSCs in biomedical research and medicine has been slowed by concerns that these cells are prone to increased numbers of genetic mutations. A new study by scientists at the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, suggests that iPSCs do not develop more mutations than cells that are duplicated by subcloning. Subcloning is a technique where single cells are cultured individually and then grown into a cell line. The technique is similar to the iPSC except the subcloned cells are not treated with the reprogramming factors which were thought to cause mutations. The researchers published their findings on February 6, 2017, in the  Proceedings of the National Academy of Sciences . "This technology will eventually change how doctors treat diseases. These findings suggest that the question of safety shouldn't impede research using iPSC," said Pu Paul Liu, M.D., Ph.D., co-author, se...

A silver bullet against MRSA: Silver ion-coated medical devices could fight MRSA while creating new bone

Image
This microscopic image shows silver-coated, stem cell-seeded scaffolds after MRSA bacteria were introduced. These medical devices can help health care providers fight MRSA while growing lost bone tissue. Credit: Mahsa Mohiti-Asli, NC State University Methicillin-resistant Staphylococcus aureus (MRSA) infections are caused by a type of staph bacteria that has become resistant to the antibiotics used to treat ordinary staph infections. The rise of MRSA infections is limiting the treatment options for physicians and surgeons. Now, an international team of researchers, led by Elizabeth Loboa, dean of the University of Missouri College of Engineering, has used silver ion-coated scaffolds, or biomaterials that are created to hold stem cells, which slow the spread of or kill MRSA while regenerating new bone. Scientists feel that the biodegradable and biocompatible scaffolds could be the first step in the fight against MRSA in patients. ...

Genetic profiling can guide stem cell transplantation for patients with myelodysplastic syndrome, study finds

In a study published in the  New England Journal of Medicine , the investigators report that genetically profiling a patient's blood cells, while factoring in a patient's age and other factors, can predict the patient's response to a stem cell transplant and help doctors select the most effective combination of pre-transplant therapies. The findings are based on an analysis of blood samples from 1,514 patients with MDS, ranging in age from six months to more than 70 years, performed in collaboration with investigators from the Center for International Blood and Marrow Transplant Research. MDS is a family of diseases in which the bone marrow produces an insufficient supply of healthy blood cells. Treatments vary depending on the specific type of MDS a patient has; donor stem cell transplants are generally used for patients with a high risk of mortality with standard treatments. "Although donor stem cell transplantation is the only curative therapy for MDS, many p...

Scientists discover an unexpected influence on dividing stem cells' fate

Image
In a dividing cell (above), tiny organs referred to as peroxisomes (inexperienced) are evenly distributed in distinctive arcs. In cells missing the protein Pex11b, peroxisomes are not allotted equally. Credit score: Laboratory of Mammalian Cell Biology and Growth at The Rockefeller College/Science When most cells divide, they merely make extra of themselves. However stem cells, that are liable for repairing or making new tissue, have a selection: They'll generate extra stem cells or differentiate into pores and skin cells, liver cells, or nearly any of the physique's specialised cell sorts. As reported February three in  Science , scientists at The Rockefeller College have found that this pivotal determination can hinge on whether or not or not tiny organ-like buildings, organelles, are divvied up correctly throughout the dividing stem cell. "To ensure that the physique's tissues to develop correctly and preserve them...

Drug could prevent infertility in cancer patients

Hermann and his research team have been pursuing a number of cutting-edge research initiatives to restore fertility in men who have lost their ability to have children as a result of cancer treatments they received as children. While working on methods to restart sperm production, the researchers discovered a link between a drug for recovering cancer patients and the absence of normal damage to reproductive ability. The drug is called G-CSF or granulocyte colony-stimulating factor. It stimulates the bone marrow to produce neutrophils, which are white blood cells that are needed to fight infections. They're commonly lost after chemotherapy and radiation treatments. "We were using G-CSF to prevent infections in our research experiments," Hermann said. "It turned out that the drug also had the unexpected impact of guarding against male infertility." Because cancer treatments like radiation and chemotherapy often kill sperm stem cells, male reproduction ca...

Ovarian hormones awaken newly discovered breast stem cells

Image
Tree of Life: Dr Anne Rios used microscopy to disclose the tree-like association of the milk-producing cells within the mammary gland throughout being pregnant. Credit score: Picture courtesy of Walter and Eliza Corridor Institute Walter and Eliza Corridor Institute researchers have used superior mobile, bioinformatics and imaging know-how to disclose a long-lived sort of stem cell within the breast that's answerable for the expansion of the mammary glands throughout being pregnant. The newly found stem cells, which reply to the 'ovarian hormones' progesterone and oestrogen , may additionally be linked to a high-risk type of breast most cancers. The invention was made by Dr Nai Yang Fu, Dr Anne Rios, Professor Jane Visvader and Professor Geoff Lindeman as a part of a 20-year analysis program into how the breast develops from stem cells, and the way breast cancers can come up from stem cells and creating breast tissue. The ana...